FindTrial
Sign In

Etude Antagonistes NMDA et douleur neuropathique

Antagonistes NMDA en relais de la kétamine dans la douleur neuropathique. - Etude Antagonistes NMDA et douleur neuropathique

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-000672-34-FR
Enrollment
Unknown
Registered
2011-05-09
Start date
2011-08-11
Completion date
Unknown
Last updated
2016-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Pulmodexane Product Name: Dextromethorphan Pharmaceutical Form: Capsule INN or Proposed INN: DEXTROMETHORPHAN CAS Number: 125-71-3 Concentration unit: mg milligram(s) Concentration type: r

Sponsors

CHU de Clermont-Ferrand
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: 0 F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 60 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

France

Contacts

Public ContactDr Gisèle PICKERING

CHU de clermont-ferrand

gpickering@chu-clermontferrand.fr0033473178416

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026